HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100013A1-1mL
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-14664F-1mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
HY-14664F-10mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
HY-14664F-5mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
HY-15701A-10mg
|
MedChemexpress LLC
|
(Z)-Leukadherin-1 [CAS 2055362-72-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-15701A-100mg
|
MedChemexpress LLC
|
(Z)-Leukadherin-1 [CAS 2055362-72-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-15701A-5mg
|
MedChemexpress LLC
|
(Z)-Leukadherin-1 [CAS 2055362-72-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-15701A-50mg
|
MedChemexpress LLC
|
(Z)-Leukadherin-1 [CAS 2055362-72-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-15701A-1mL
|
MedChemexpress LLC
|
(Z)-Leukadherin-1 [CAS 2055362-72-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-P74438-10ug
|
MedChemexpress LLC
|
14-3-3 sigma, Mouse
|
|
|
|
HY-P74438-100ug
|
MedChemexpress LLC
|
14-3-3 sigma, Mouse
|
|
|
|
HY-P74438-5ug
|
MedChemexpress LLC
|
14-3-3 sigma, Mouse
|
|
|
|
HY-P74438-50ug
|
MedChemexpress LLC
|
14-3-3 sigma, Mouse
|
|
|
|
HY-P74438-500ug
|
MedChemexpress LLC
|
14-3-3 sigma, Mouse
|
|
|
|
HY-P74437-100ug
|
MedChemexpress LLC
|
15 Lipoxygenase 2, Human (sf9)
|
|
|
|
HY-P74437-20ug
|
MedChemexpress LLC
|
15 Lipoxygenase 2, Human (sf9)
|
|
|
|
HY-P7125-10ug
|
MedChemexpress LLC
|
4-1BB/TNFRSF9, Human
|
|
COVID-19-immunoregulation
|
|
HY-P7125-50ug
|
MedChemexpress LLC
|
4-1BB/TNFRSF9, Human
|
|
COVID-19-immunoregulation
|
|
HY-D0807-5mg
|
MedChemexpress LLC
|
5-IAF [CAS 63368-54-7]
|
|
Cancer-programmed cell death
|
|
HY-N6010-1mg
|
MedChemexpress LLC
|
8-Hydroxybergapten [CAS 1603-47-0]
|
|
|
|
HY-N6010-5mg
|
MedChemexpress LLC
|
8-Hydroxybergapten [CAS 1603-47-0]
|
|
|
|